AI assistant
INSMED Inc — Director's Dealing 2023
Oct 31, 2023
30150_dirs_2023-10-31_ea35671e-f305-4128-954b-352bc9e14612.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2023-10-27
Reporting Person: Lewis William (Director, Chair and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-10-27 | Common Stock | M | 53363 | $14.24 | Acquired | 53363 | Indirect |
| 2023-10-27 | Common Stock | S | 53363 | $24.04 | Disposed | 0 | Indirect |
| 2023-10-27 | Common Stock | M | 1322 | $14.24 | Acquired | 1322 | Indirect |
| 2023-10-27 | Common Stock | S | 1322 | $25.08 | Disposed | 0 | Indirect |
| 2023-10-27 | Common Stock | M | 315 | $14.24 | Acquired | 315 | Indirect |
| 2023-10-27 | Common Stock | S | 315 | $26 | Disposed | 0 | Indirect |
| 2023-10-27 | Common Stock | M | 500 | $14.24 | Acquired | 500 | Indirect |
| 2023-10-27 | Common Stock | M | 55350 | $14.24 | Acquired | 289274 | Indirect |
| 2023-10-27 | Common Stock | S | 55350 | $24.04 | Disposed | 233924 | Indirect |
| 2023-10-27 | Common Stock | M | 1323 | $14.24 | Acquired | 235247 | Indirect |
| 2023-10-27 | Common Stock | S | 1323 | $25.05 | Disposed | 233924 | Indirect |
| 2023-10-27 | Common Stock | M | 327 | $14.24 | Acquired | 234251 | Indirect |
| 2023-10-27 | Common Stock | S | 327 | $26 | Disposed | 233924 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-10-27 | Stock Option (right to buy) | $14.24 | M | 55000 | Disposed | 2023-10-31 | Common Stock (55000) | Indirect |
| 2023-10-27 | Stock Option (right to buy) | $14.24 | M | 500 | Disposed | 2023-10-31 | Common Stock (500) | Indirect |
| 2023-10-27 | Stock Option (right to buy) | $14.24 | M | 57000 | Disposed | 2023-10-31 | Common Stock (57000) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 342648 | Direct |
Footnotes
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: By ARTICLE 4 TRUST UNDER WILLIAM LEWIS FAMILY LEGACY TRUST U/A11/1/2020
F3: This is the weighted average sales price representing 53,363 shares sold at prices ranging from $23.68 to $24.60 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4: This is the weighted average sales price representing 1,322 shares sold at prices ranging from $24.83 to $25.40 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5: By ARTICLE 4 KATIE PROCTER DYNASTY TRUST
F6: This is the weighted average sales price representing 55,350 shares sold at prices ranging from $23.65 to $24.63 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F7: This is the weighted average sales price representing 1,323 shares sold at prices ranging from $24.83 to $25.40 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F8: Includes 1,303 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
F9: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable and were scheduled to expire on October 31, 2023.